Further support of this prognostic impact of tumour cell PD-L1 and of tumour PD-L1 being a marker of TIL antitumour response in melanoma, is given by Kluger et al. and Thierauf et al. [22,40]. The gene discussed is CD274; the disease is neoplasm.